Christy Mnzava
Family Medicine · Meridian, MSNPI 1619154051
Payments from drug & device makers
Across 189 payments — averaging $36.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Amgen$798
- Novo Nordisk$683
- Johnson & Johnson$616
- AbbVie$519
- Lilly USA, LLC$281
- plus $752 from 10 others
What the payments were for
- Food & beverage$6,841100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $3,192 |
| Amgen(2 entities) | 41 | $798 |
| Novo Nordisk | 16 | $683 |
| Johnson & Johnson | 13 | $616 |
| AbbVie(2 entities) | 18 | $519 |
| Lilly USA, LLC | 20 | $281 |
| Bayer | 4 | $254 |
| Boehringer Ingelheim | 3 | $131 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| GSK | 2 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Merck | 2 | $29 |
| Exact Sciences | 1 | $23 |
| Dexcom, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,841 in reported general payments places this provider in the 85th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 101 | $92,336 |
| OzempicSemaglutide | 59 | $87,328 |
| JardianceEmpagliflozin | 47 | $51,574 |
| LinzessLinaclotide | 49 | $50,091 |
| EliquisApixaban | 44 | $47,727 |
| MounjaroTirzepatide | 30 | $39,175 |
| Xigduo XrDapaglifloz Propaned/Metformin | 64 | $37,190 |
| JanuviaSitagliptin Phosphate | 25 | $29,775 |
| XareltoRivaroxaban | 16 | $19,671 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $19,213 |
| MyrbetriqMirabegron | 15 | $15,791 |
| TrulicityDulaglutide | 11 | $10,110 |
| KerendiaFinerenone | 14 | $10,077 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 180 | $6,064 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $5,801 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $3,192 | $111,550131 claims |
| Novo NordiskOzempic, Novolog Mix 70-30 | $683 | $90,61880 claims |
| Boehringer IngelheimJardiance | $131 | $51,57447 claims |
| AbbVieLinzess | $519 | $50,09149 claims |
| Lilly USA, LLCMounjaro, Trulicity | $281 | $49,28541 claims |
| MerckJanuvia | $29 | $29,77525 claims |
| Johnson & JohnsonXarelto | $616 | $19,67116 claims |
| BayerKerendia | $254 | $10,07714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Meridian
- Douglas PhillipsMeridian$11K
- Shawn AndersonMeridian$10K
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.